Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study.
Winer ES, Safran H, Karaszewska B, Bauer S, Khan D, Doerfel S, Burgess P, Kalambakas S, Mostafa Kamel Y, Forget F. Winer ES, et al. Among authors: safran h. Int J Hematol. 2017 Dec;106(6):765-776. doi: 10.1007/s12185-017-2319-9. Epub 2017 Sep 1. Int J Hematol. 2017. PMID: 28864871 Clinical Trial.
Clinical features of patients with MTAP-deleted bladder cancer.
De Souza AL, Mega AE, Douglass J, Olszewski AJ, Gamsiz Uzun ED, Uzun A, Chou C, Duan F, Wang J, Ali A, Golijanin DJ, Holder SL, Lagos GG, Safran H, El-Deiry WS, Carneiro BA. De Souza AL, et al. Among authors: safran h. Am J Cancer Res. 2023 Jan 15;13(1):326-339. eCollection 2023. Am J Cancer Res. 2023. PMID: 36777505 Free PMC article.
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
Kindler HL, Richards DA, Garbo LE, Garon EB, Stephenson JJ Jr, Rocha-Lima CM, Safran H, Chan D, Kocs DM, Galimi F, McGreivy J, Bray SL, Hei Y, Feigal EG, Loh E, Fuchs CS. Kindler HL, et al. Among authors: safran h. Ann Oncol. 2012 Nov;23(11):2834-2842. doi: 10.1093/annonc/mds142. Epub 2012 Jun 13. Ann Oncol. 2012. PMID: 22700995 Free article. Clinical Trial.
Cellular immunotherapy for refractory hematological malignancies.
Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, Butera JN, Quesenberry MI, Young CT, Quesenberry PJ. Reagan JL, et al. Among authors: safran h. J Transl Med. 2013 Jun 19;11:150. doi: 10.1186/1479-5876-11-150. J Transl Med. 2013. PMID: 23782682 Free PMC article. Clinical Trial.
Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia.
Reagan JL, Fast LD, Nevola M, Mantripragada K, Mulder A, Claas FH, Rosati K, Schumacher A, Safran H, Young CT, Quesenberry MI, Winer ES, Butera JN, Quesenberry PJ. Reagan JL, et al. Among authors: safran h. Blood Cancer J. 2015 Dec 4;5(12):e371. doi: 10.1038/bcj.2015.100. Blood Cancer J. 2015. PMID: 26636286 Free PMC article. Clinical Trial. No abstract available.
165 results